Nutra Pharma says Pure Raw Supplies gains control with 62.63% voting power after Series B transfer

• Nutra Pharma control shifted on Aug. 21, 2026, following a transfer of Series B Preferred Stock with supermajority voting rights.
• Pure Raw Supplies received 12 million Series B Preferred shares from Rik Deitsch as a gift for no consideration.
• Pure Raw Supplies now holds 62.63% of total voting power, replacing Deitsch as the controlling stockholder.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutra Pharma Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041208), on September 02, 2026, and is solely responsible for the information contained therein.